Collectively, these in vivo data suggest that the potent anti-tumor activity of JQ1(+) in Ewing Sarcoma is mediated through its inhibitory effects on the EWS-Fli1oncogene expression and its transcriptional targets. Here, EWSR1 is linked to neoplasm.